ArticleBritish journal of haematology2025
Efficacy and safety of luspatercept with or without erythropoiesis-stimulating agent in patients with myelodysplastic neoplasms with ring sideroblasts: A multicentre real-life study by the GFM.
Maud D'Aveni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.